Shares surge over 76% as the company secures Nevada Tech Hub funding and a key U.S. patent for its charging technology.
Health insurer's stock rallies as it maintains financial targets despite recent Medicare Star Ratings challenges.
Singapore-based security firm Concorde International Group sees massive trading volume without any apparent news catalyst, prompting investor caution.
Government award will advance the company's non-vaccine influenza therapeutic, CD388, and onshore its manufacturing ahead of a potential pandemic.
The bank projects a near-term price target of $135,000 for Bitcoin, citing heavy ETF inflows and a break from historical post-halving patterns.
Regulators expedite review for ALTO-101, targeting a key aspect of schizophrenia with no currently approved treatments.
Major indices post gains with the S&P 500 touching a new high as investors anticipate potential monetary easing from the Federal Reserve.
Internal U.S. Army memo flags 'fundamental security' vulnerabilities in a key battlefield communications network, raising contract concerns.